Loading data for DWTX — first visit, this takes a few seconds.
Dogwood Therapeutics Inc. (DWTX)
NasdaqCM: DWTX
· Real-Time Price · USD
2.66
-0.02 (-0.75%)
At close: Aug 27, 2026, 8:00 PM
2.35
+1.29%
After-hours: 7:46 PM
The price, the headline numbers and the latest news, in one place.
Dogwood Therapeutics Inc. (DWTX) Stock Price, Analysis & Data
-0.75% (1D)
No data available
| Bid | 2 |
| Market Cap | 78.86M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -36.04M |
| 1.76 | |
| 1.89 | |
| 1.23 | |
| -0.36 | |
| P/B (ttm) | 1.14 |
| P/S (ttm) | n/a |
| Earnings Date | May 14, 2026 |
| Ask | 3.32 |
| Volume | 120,552 |
| Avg. Volume (20D) | 74,942 |
| Open | 2.70 |
| Previous Close | 2.68 |
| Day's Range | 2.60 - 2.79 |
| 52-Week Range | 1.28 - 9.50 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About DWTX
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clini...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 17, 2020
Employees 8
Stock Exchange NasdaqCM
Ticker Symbol DWTX
Website https://dwtx.com
Financial Performance
In 2025, Dogwood Therapeutics's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -34.26M, an increase of 177.39%.
Financial StatementsEarnings Surprise
Dogwood Therapeutics has released their quarterly earnings on Aug 13, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.34 misses estimates by -0.20, with 82.91% YoY growth.
Dogwood Therapeutics Inc. is scheduled to release its earnings on May 14, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
